Archive: 19/02/2019

Oncotype DX not cost-effective for low-risk breast cancer

(HealthDay)—The multigene expression test Oncotype DX (ODX) is not cost-effective for women with breast cancer who are at low risk for recurrence, according to research published online Jan. 22 in the Journal of the National ...

Feb 19, 2019

0

3

Darolutamide slows spread of castration-resistant prostate cancer

(HealthDay)—Metastasis-free survival is significantly longer among men with nonmetastatic, castration-resistant prostate cancer treated with darolutamide versus placebo, according to a phase 3 study published online Feb. ...

Feb 19, 2019

0

1

Researchers key to advance care planning with cancer clinical trial patients

Cancer clinical trials are an important option for patients with cancer. Yet, once a trial ends, patients still need care plans. Little is known at what point during clinical trial transitions to initiate advance planning ...

Feb 19, 2019

0

1

Lower self-perception observed in children with amblyopia

(HealthDay)—Children with amblyopia have significantly lower mean peer acceptance and physical competence scores at age 3 to 7 years, according to a study published online Feb. 14 in JAMA Ophthalmology.

Feb 19, 2019

0

5

Researchers develop new one-two punch against melanoma in mouse model

Researchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University School of Medicine report two new forms of an older anti-cancer agent they developed appear to enhance ...

Feb 19, 2019

0

43

Living near convenience stores could raise risk of artery-clogging condition

Convenience stores may be handy, but they may not be healthy for your arteries.

Feb 19, 2019

0

2

Could 'Cardio-obstetrics' curb rise in pregnancy-related deaths?

More collaboration between cardiologists and obstetricians could help curb the nation's soaring death rate among pregnant women, according to a new report urging more team-based care for these vulnerable mothers.

Feb 19, 2019

0

0

Should you get tested for the 'Breast cancer genes'?

(HealthDay)—Women who have specific mutations in genes known as BRCA are at increased risk for breast and ovarian cancers. Now, an influential expert panel reaffirms that certain women should be screened for the genes.

Feb 19, 2019

0

1

Screen time for the very young has doubled in 20 years: study

(HealthDay)—The electronic babysitter is alive and thriving in the new digital age.

Feb 19, 2019

0

0

Research shows structural barriers are the biggest reason for low participation in clinical trials

A research team led by the Fred Hutchinson Cancer Research Center have determined the most significant barriers to clinical trial participation. The study published today in Journal of the National Cancer Institute (JNCI) ...

Feb 19, 2019

page 3 from 8

«
»